German TV show features mission of Alzheimer’s Germ Quest, Inc., reports Dr. Leslie Norins, CEO

German news show profiles American couple offering $1 million to any scientist who can prove a germ triggers Alzheimer's.

The volume of media inquiries we received attests to the fact that the public is now demanding fresh approaches to AD research be funded.”

— Dr. Leslie Norins

NAPLES, FL, UNITED STATES, July 13, 2018 / — The popular German TV show, Nano, on 3 SAT, which some liken to America’s “60 Minutes”, recently presented as its lead segment an interview with Leslie Norins, MD, PhD, CEO of Alzheimer’s Germ Quest, Inc. (AGQ), and his wife Rainey, Vice President, discussing the possibility that germs might play a role in the causation of Alzheimer’s disease (AD).

Several months ago, the German show’s producers became interested in fresh thinking about the possible triggers of AD and spotted a news item about the launch of AGQ’s project to help accelerate and deepen research on the likely participation of infectious agents. They sent a film crew to Naples for a detailed interview of the Norins’.

The entourage also went to a local senior center to observe and film how it conducts half-day classes, such as arts and crafts, for Alzheimer’s patients, so as to provide respite for their caregivers. The great impact made by meeting the patients led AGQ to propose the creation of “boot camps” to expose new AD researchers to the cognition deterioration the AD process inflicts on formerly vibrant seniors.

The German film crew remarked on how “open” American families were about a member’s having AD. They said that sometimes in Germany there is a kind of shame associated with the diagnosis, and so it is kept veiled in some cases.

Dr. Norins said that following the show’s broadcast in Germany, numerous emails were received from viewers there. He took this as a sign citizens there were as eager for research progress as those in the U.S.
Dr. Norins believes this show, and numerous other media inquiries he has received attest to the fact that the public is now demanding fresh approaches to AD research be funded, in addition to the older standbys of amyloid plaques and protein tangles.

Alzheimer’s Germ Quest, Inc. is a public benefit corporation headquartered in Naples Florida. Its mission is to accelerate and deepen scientific investigations into the possible role of infectious agents as the root cause of Alzheimer’s disease. It is the sponsor of the $1 Million Alzheimer’s Germ Quest Challenge Award for scientists. (

Mollie Page
Page Print Communications
email us here

Source: EIN Presswire

Providing Additional Knowledge to Help Improve Your Immune System by Dr. Susana Trujillo

Best Fucoidan

Best Fucoidan Product

Best Fucoidan Extracts

Cancer is as unique as each of the affected body tissues and the person who faces it.

You should not use this information to diagnose or treat any health problems or illnesses without consulting your physician. Please consult a doctor with questions you may have about your condition.”

— Dr. Susana Trujillo

NEW YORK, NY, UNITED STATES, July 12, 2018 / — Nutritional knowledge to help improve your immune system by Dr. Susana Trujillo

Cancer is as unique as each of the affected body tissues and the person who faces it. Therefore, Dr. Susana’s mission is to help you improve your condition by providing you with additional educational knowledge that will help you reinforce your immune system to fight cancer.

Because it is a long process, and more of a sustained effort on many levels of your awareness you must incorporate a wise and very detailed strategy to overcome the inner conflicts and frictions that are debilitating your immune system, which is your vital force. To heal from an advanced cancer, you need to regain as much energy as possible from all the aspects of your life. It requires inner reassessments in order to regain optimal health and functioning. For example, one benefit of brown seaweed nutrition is the Fucoidan content. Fucoidan is another much needed natural ingredient to help with energy levels, and contributes to a reduction in tiredness and fatigue.

As for what I consider to be the physical supplies, the basics are: good clean food, water, air, sunlight, shelter, meaningful work and relationship to the human community and rest. In recent years, many compassionate suppliers and professionals have been helping to improve the quality and availability of these basics. Since the most effective tools for improving health are often concentrates of foods or minerals, and many powerful therapies apply specific forms of these other provisions for health, I count myself among that group.

Specific protocols for different cancers are as complex and multifaceted as the caring professionals who devise them. Every year alternative-minded healers have grown in sophistication and effectiveness.

Following are some understandings about cancer that many health professionals agree upon:

· The toxic chemicals that enable much of our modern lifestyle are often found to have slight hormonal effects, and these are usually estrogenic. A comparison between the effects of estrogen on any vertebrate and the effects of a malignant cancer would highlight many parallels.

· Cancer thrives in a glycolysis environment, where the energy it needs is produced from the breakdown of sugar. Cancer declines or fails to thrive when cellular respiration is primarily the oxygen-rich metabolic event known as the Krebs Cycle.

· Chronic sustained stress and trauma to a cell, tissue, or organ will dramatically increase the likelihood of a cancer. This stress might be mechanical, chemical, or energetic. Chronic excesses of poor nutrition or deficiencies of necessary nutrients have caused this sustained stress and trauma for much of humanity and its history.

· Re-establishing the parameters of healthy balance, which our ancestors described as “aligning with natural law,” will enable any living being to recover from disease and regain health; that is, if there is reasonable time and vital energy to work with.

· When a cancer is diagnosed, the energetics of health for that person and the affected tissue should be understood by the diagnosing provider.

· The physician or health professional who diagnoses cancer should also explain these factors to patients and family members who are concerned. If this is not your experience with cancer treatment, keep looking.

Dr. Susana’s Anti-Cancer Natural Supplies

Below I am attaching a partial list of some natural ingredients scientifically proven to help manage common symptoms associated with anaerobic disorders. These include ingredients that can support the immune system to control the side effects caused by the treatments.

1. NatureMedic™ Fucoidan powered with AHCC®—This innovative product contains Fucoidan extracted from brown seaweeds, which contribute to apoptosis within the cancer cell according to reports from Japanese and Russian researchers. Other effects most noted are the protection of the patient’s digestive functions and alternative benefits for the thyroid metabolism. It also contains a healthful ingredients known as AHCC® (Active Hexose Correlated Compound) to more widely support the immune system and antioxidant activity in people who consume it as directed.

What makes this brand different for other Fucoidan brands?

From the idea to the finished product, this dietary supplement is considered a premium brand. NatureMedic™ Fucoidan was optimized with AHCC® to support and improve the Quality of Life of many people. This brand uses TWO species to extract the Fucoidan from: MOZUKU AND MEKABU (WAKAME). NatureMedic™ Fucoidan powered with AHCC® contains CERTIFIED ORGANIC FUCOIDAN extracted from the MEKABU SPORES. This means that you do not have to question the fact that these products might be contaminated.

​Besides Fucoidan, it also contains two mushroom extracts: Agaricus blazei Murill and AHCC® (Active Hexose Correlated Compound). Fucoidan powered with AHCC® is an exclusive and innovative blend that combines high-quality Fucoidan extracted from Okinawa Mozuku and Australian Mekabu Fucoidan. This unique combination contains AHCC®, a cultured mushroom mycelia extract that is rich in alpha glucans.

2. Iodine—This is a remarkable “smart mineral” which has been widely known as deficient in most Americans for many years. This form is a well-studied and absorbable form of Iodine, and it’s another affordable and effective support for complex conditions of metabolic imbalance.

3. DIM—Di-Indoly Methane (DIM) is a gift from the cabbage plant family that is proven to help the liver metabolize estrogens into beneficial byproducts.

4. Calcium D-Glucarate—This is a highly absorbable version of Glucaronic acid, which helps the liver with Phase 2 detoxification tasks–the specific pathway most challenged by complex petrochemicals and pollutants.

5. Vitamin D3—This “sunshine” vitamin is extensively referenced in medical literature as being protective of blood calcium levels. It is also proven to contribute to the protection of hormone levels in the blood, as well as the defense against some cancers.

The many various cancer types and locations require specific support for their respective organ functions and protection from stress. This support can be achieved by the intelligent use of many natural foods and products.

Dr. Susana Trujillo
Dr. Susana Trujillo
email us here

Best Fucoidan Products

Source: EIN Presswire

Adaptive Computing Changes Product Name from “Moab” to “Moab Cloud for the HPC Suite”

The name change more accurately describes the product’s new capabilities.

More than 2400 companies are interested in our Moab Cloud Solution, and we’re performing several Test Drives of the product every week”

— Arthur Allen, President & CEO, Adaptive Computing.

NAPLES, FL, UNITED STATES, July 12, 2018 / — Adaptive Computing Enterprises, a world leader in dynamically optimizing large-scale HPC computing environments, announced that it has changed the name of its flagship software product “Moab” to “Moab Cloud for the HPC Suite.” The new name more accurately reflects the product’s additional cloud-bursting capabilities.

For more than 10 years, administrators have relied on Moab more than any other HPC workload management solution because of its demonstrated ability to optimize scheduling and accelerate the workload productivity of their systems. It is currently in use at the largest and most complex high-performance computing environments in the world, including many leading commercial and innovative research HPC systems.

Moab Cloud for the HPC Suite adds a new level of benefits for HPC ecosystems by combining the time-tested elements of Moab with advanced cloud-bursting capabilities. The new solution can “burst” additional workloads to an external cloud on-demand. It is easy to use, manage, and configure and integrates with on-premise resources. It offers full stack provisioning, is automated, and is very cost-effective for customers.

Adaptive Computing Enterprises was acquired in September 2016 by software mogul Arthur L. Allen, a long-time industry veteran who has been creating software companies and technology solutions for 40 years. The company has been totally transformed through millions of dollars of investment in development, taking Moab to the next level. Adaptive Computing will continue to lead the market through product innovation, product quality and extraordinary customer support.

“More than 2400 companies are interested in our Moab Cloud Solution, and we’re performing several Test Drives of the product every week,” Allen said.

Combining the capabilities of public clouds with on-premise infrastructure brings unparalleled flexibility and scalability to the business. Moab Cloud for the HPC Suite has evolved into the premiere, best-in-class solution offering increased agility, cost reduction and unprecedented productivity.

About Adaptive Computing

Adaptive Computing manages some of the world’s largest computing installations. Our leadership in IT decision engine software has been recognized with over 45 patents and over a decade of battle-tested performance resulting in a solid Fortune 500 and Top500 supercomputing customer base.

Adaptive Computing’s mission is to bring higher levels of decision, control, and self-optimization to the challenges of deploying and managing large and complex IT environments, so they accelerate business performance at a reduced cost.

For more information, contact Sue DeGram, Director of Marketing at Adaptive Computing Enterprises Inc.

Sue DeGram
Adaptive Computing Enterprises Inc.
email us here

Moab/NODUS Cloud Bursting Presentation and Demo

Source: EIN Presswire

Critically Important Book Released on Opioid Crisis by Simon A. Zysman, Ph.D.

 Successful Heroin and Opioid Addiction Treatment,

Successful Heroin and Opioid Addiction Treatment,

 Successful Heroin and Opioid Addiction Treatment,

Successful Heroin and Opioid Addiction Treatment,

Details treating addiction with high rate of success using breakthrough approach; includes contributions from several other specializing professionals.

The idea of treating addiction with only behavioral intervention is outdated and ineffective…you're not doing justice to the patient by giving them the least workable option,”

— Simon A. Zysman, Ph.D.

COMMACK, NEW YORK, UNITED STATES, July 11, 2018 / — NEW YORK, NY – Dr. Simon Zysman is one of the nation's most prominent and well known clinical psychologists in the treatment of the addiction to heroin and opioids (the most commonly prescribed pain medication).

In Successful Heroin and Opioid Addiction Treatment, announced today, Dr. Simon A. Zysman shares his vast experience in recovery treatment as well as a deep look into his incredibly effective treatment program setting former addicts upon a positive road to recovery and a productive future. Opioid dependency is currently considered a lethal epidemic that has run rampant throughout the United States. The spread of opioid addiction is shockingly more by medical doctors inadvertently over-prescribing highly-addictive painkiller medication to their patients as opposed to illegal drug dealers. Dr. Zysman's success in treating this vicious addiction goes against the grain when it comes to the techniques utilized by many recovery specialists.

Dr. Zysman's reputation is such that he was invited to address the New York State Senate Task Force on Heroin and Opiate Addiction on his groundbreaking treatment methodology. It was there Dr. Zysman was asked to write a book about the approach. Thus, a two-year effort began that has culminated in the publication of Successful Heroin and Opioid Addiction Treatment, an amazing look at the vitally important work of Dr. Zysman.

This book released also includes contributions from several specializing medical professionals such as Steven J. Blander, M.D. Board Certified in Internal Medicine and Infectious Disease, Melinda T. Del Castillo M.D. Psychiatrist and Addition Medicine, Regina Neuman, M.D. Internal Medicine and Addiction Medicine, Steven M. Silverman, M.D. Board Certified in Addiction Medicine, Isabel M. Tolentino-Marasol, M.D. Board Certified Psychiatrist and Addiction Medicine, Farhaana Zainul, J.D., CASAC Health Law and Quality Assurance, Jacqueline P. Zysman-Weisfeld, Pharm. D. Pharmacist, Matthew L. Zyzman, LMSW Clinical Social Worker and Addiction Specialist.

For more information about Employee Assistance Resource Services, Inc., located in Smithtown Long Island, visit and for information on ordering a copy of the book, Successful Heroin and Opioid Addiction Treatment, please visit

Media related inquiries with the Doctor, bookings, interview requests, etc., can be directed to John Colascione, Long Island Media Inc., 67 Harned Road, Commack, NY 11725, Phone: 631-406-4410.

Long Island Media Inc.
email us here

Source: EIN Presswire

Integrative Healer Shirley Furman to be Featured on CUTV News Radio

IRVINE, CALIFORNIA, UNITED STATES, July 11, 2018 / — Creating new habits can be extremely difficult if not impossible. We will often avoid change until we have no other choice. Fortunately, the healthy version of you is not the exception to the rule; there are fundamental tools we all have at our disposal to create new habits and live the healthy life we were born to live.

Shirley Furman is a nurse practitioner and integrative healer. Integrative healers provide healthcare with a focus on the whole person, using different methods to meet the specific needs of the client.

“I love what I do as a nurse practitioner and I love being able to use medication to help people who need it,” says Furman, “but after doing this for 20 years, I’ve found a lot of people use antidepressants and even tranquilizers to help with anxiety or depression, when they just need healthier, less expensive, tools to improve their health. My goal is to give people as many of the fundamental tools and habits so they can get off their meds or not even start them.”

According to Furman, a vast majority of our issues are actually the result of sleep deprivation. She helps her patients reclaim their health and wellness through a combination of hypnotherapy and sleep restoration.

“Sleep is something we're born doing, we take it way too much for granted,” says Furman. “So let's try the simple solutions first. Restful sleep can be a bigger life changer than exercise or nutrition. When you're not getting enough sleep, you're more vulnerable. With adequate sleep you make better decisions. It’s a great integrative tool and it’s free!”

Most of us can be successful for short periods, but the biggest challenge is maintaining it after we’re reached our goal and working it into our lifestyle. Furman says hypnotherapy can help ease that transition by connecting with our subconscious.

“Medicine can change people's lives, but if there's a way to take care of the problem without medication, then I'm all for it. I believe in the power of hypnotherapy because it is so fast and powerful,” says Furman. “The goal is to develop new habits and incorporate them into our lifestyle, but we tend to ignore our subconscious. With hypnotherapy I find I can change my patient’s lives faster and easier with no side effects.”

CUTV News Radio will feature Shirley Furman in an interview with Jim Masters on July 11th at 4pm EDT.

Listen to the show on BlogTalkRadio.

If you have a question for our guest, call (347) 996-3389.

For more information on Shirley Furman, visit

Lou Ceparano
(631) 850-3314
email us here

Source: EIN Presswire

Major Upgrade for Patentcloud Announced by InQuartik

Quality Insights provides a deeper dive into the quality of a patent.

Patentcloud is proud to present the new Quality Insights.

InQuartik unveils a major upgrade for Patentcloud, with the new Quality Insights and claim-chart formatted Prior Art Comparison, among other enhancements.

Patentcloud’s upgrades, in particular Quality Insights and its new Prior Art Comparison, are truly a breakthrough for the patent litigation and transaction markets.”

— Leon Hsu of InQuartik

TAIPEI, TAIWAN, TAIWAN, July 11, 2018 / — InQuartik, a global software company, has announced a major upgrade to Patentcloud, its AI-powered patent intelligence platform. These new enhancements have come together to make Patentcloud even more powerful—and even more user-friendly.

At the top of the list is the new Prior Art Comparison. This exciting new feature quickly aligns the claims of a patent to the prior art in the prosecution and then displays the results in an easy-to-read claim-chart format.

As a better index for reading all of the claims, the new Prior Art Comparison feature enables users to better understand not only the relationship of the prior art to the claims but also the context and examiner’s opinions. With it, users can immediately understand the difference between the claimed invention and the prior art in the prosecution—in other words, the gist of the invention, which can also benefit claim construction.

Prior Art Comparison is one of the new features in what is now called Quality Insights (formerly Validity Insights). This new name reflects how this product now delivers insights not only into the validity but also the quality of a patent at a deeper level.

Quality Insights also now has a convenient Family Prior Art feature, which includes patent family data from the USPTO as well as from the other IP5 offices and WIPO. With all of the family prior art consolidated in one comprehensive overview and the§102 and 103 citations highlighted, users can save time and quickly focus their attention on their validity/invalidity evaluations.

Another Patentcloud product, Patent Search, has received an upgrade of its own to the technical architecture of its Project feature. This improvement has not only optimized performance, but it also includes a new user interface.

In addition, with My Folder, Patent Search basic users can manage up to 2,000 patents in 20 folders, with up to 10 file levels. Premium users also have access to My Folder, plus an additional Project, in which they can manage up to 100,000 patents in 1,000 folders, with up to 10 file levels.

The new Project feature also facilitates collaboration among a wide range of people, from patent professionals to engineers, by enabling premium users to share analysis results with basic members.

“Patentcloud’s upgrades, in particular Quality Insights and its new Prior Art Comparison, are truly a breakthrough for the patent litigation and transaction markets, since they make the quality of patents transparent in just a few clicks,” said Leon Hsu, director of Product Development at Patentcloud. “And the new enhancements to the Project feature are enabling higher performance and even greater collaboration and sharing of information, enabling Patentcloud, in turn, to become a collaborative workspace for patent professionals and their stakeholders.”

To learn more about Patentcloud and these exciting new upgrades, visit, or to try these new products and features yourself, visit

Patentcloud is a patent intelligence platform that leverages artificial intelligence and big data analytics for better business decisions. Patentcloud delivers actionable insights through its three products—Quality Insights, Patent Search, and Design Search.

InQuartik is a global software company that specializes in artificial intelligence and big data analytics. With a mission to organize key data and discover business insights for impactful decisions, InQuartik utilizes high-quality data, innovative software, AI technology, and big data analytics to derive wisdom from data to empower the world. Find out more about InQuartik at

Ted Pigott
email us here

Source: EIN Presswire

Goliath Resources Commences 2018 Exploration, Highly Prospective for Major Gold and Copper Discovery, Golden Triangle BC

Goliath’s Prosperity Bullseye Zone

11 metre Copper and Silver sample open at surface

GOT.V projects proximal to Golden Triangle

When drilling begins Goliath Resources Ltd. (TSX-V: GOT) (Frankfurt: B4IE) will start in high-grade mineralization, the only question is how deep and what grade

Goliath Resources Limited (TSX:GOT)

Goliath Resources has recently been the subject of several advisories, including mining analyst Bob Moriarty and Portfolio Manager John Newell of Fieldhouse Capital Management.”

— MMW Journal

NEW YORK, NY, USA, July 11, 2018 / — Goliath Resources Limited (TSX-V: GOT) (Frankfurt: B4IE) announced the initiation of its surface exploration programs on both its Copperhead and Lucky Strike properties located proximal to the Golden Triangle in British Columbia. The Company is planning to drill highly prospective virgin targets this 2018 which were previously under glaciers that only recently retreated, exposing exceptional Gold, Silver, and Copper mineralization at surface.

The following URLs have been identified for further insight on Goliath Resources Ltd.:
– Company website:
– Recent Mining MarketWatch Journal article:
– Recent CEO Interview:

Goliath Resources Founder and CEO, Roger Rosmus, was interviewed recently by Dr. Allen Alper, PhD Economic Geology and Petrology, Columbia University, NYC (we have provided excerpt copy of interview below). Goliath Resources has recently been the subject of several advisories, including mining analyst Bob Moriarty and Portfolio Manager John Newell of Fieldhouse Capital Management, regarding exceptional valuation-creation potential as the Company prepares to drill two of its four properties this summer-2018 proximal to the Golden Triangle in British Columbia. A very real possibility exists for investors to experience a major appreciation in share price when Goliath announces initial drill results. Analogies for what GOT.V investors have potential to see are what happened to the share prices of GT Gold Corp. (TSX-V: GTT $0.20 to $2.76) and Garibaldi Resources Corp. (TSX-V: GGI $0.20 to $2.76) when they hit their discovery drill holes in 2017.

Interview excerpt:
Goliath Resources Limited (TSX-V: GOT, Frankfurt: B4IE) is a project generator of precious metals projects, focused in the prolific Golden Triangle and surrounding area of northwestern British Columbia. It controls 100% of four highly prospective properties that include Bingo, Golddigger, Lucky Strike and Copperhead, covering over 44,000 hectares. All four properties have brand new discoveries, never drilled before, that all have returned anomalous gold, silver and/or copper in soils, grab and channel samples from exposed bedrock at surface over large areas. We learned from Roger Rosmus, Founder and CEO of Goliath Resources Limited, a veteran investment banker, that as project generator, they are looking for projects that are elephant size, that are new and that will tick all the boxes for any senior mining company to do a joint venture, a strategic investment, or a potential takeout. Their new discoveries are the product of glacial recession and permanent snowpack melting due to the recent climate change resulting in widespread hybrid mineralization at surface over large areas seen for the first time; truly a once in a life time event. The main focus, in 2018, includes drilling of brand new discoveries at their Lucky Strike and Copperhead projects

Dr. Allen Alper: This is Dr. Allen Alper, Editor-in-Chief of Metals News, interviewing Roger Rosmus, the Founder and CEO of Goliath Resources. Could you give our readers/investors an overview of yourself, your company, your focus and current activities?

Roger Rosmus: I've been in the investment banking world for over 25 years, primarily raising capital for private and public companies, many have been in the resource sector. When I saw this package of assets, I literally fell off my chair, in awe, because this is a once in a life time opportunity. I've never seen anything so spectacular as these four projects in my entire career that also have similarities to GT Gold Corp. (TSX-V: GTT) and Garibaldi Resources Corp. (TSX-V: GGI) projects before they drilled.

After the company was incorporated, we raised 2.2 million dollars and completed a RTO transaction in October of 2017. We are currently trading on the TSX venture, under the symbol GOT, and more recently, we listed on a Frankfurt, the ticker being B4IE. With the 2.2 million raised, we took options on four projects in the golden triangle and surrounding area from the J2 Syndicate, a private company and precious metals project generator. Golddigger and Bingo projects are within the triangle, and we have two projects, just south of there, around Terrace & Smithers, BC, which are Lucky Strike and Copperhead.

In addition to taking the four property options, we also acquired a 10 percent interest in a private syndicate called DSM, which staked six projects far south of Terrace. Goliath will receive 10 percent of all the economics in relation to any deals on these projects, that could potential provide non-dilutive cash flow for the company down the road.

Our business model is purely a project generator of precious metal projects that are new discoveries and elephant size. We are looking for new large projects in the right geological setting that will tick all the boxes for any senior mining company to do a potential joint venture, strategic investment, or a potential takeout. If they don’t tick all the boxes, we're not going to waste our time on it. As we all know, grass roots exploration is a high-risk business, and we’ll do anything to help mitigate some of these risks. We're looking for new discoveries that are highly mineralized, large and obvious, which we have found at all four projects. Attracting a senior partner increases the probability of success and getting a material project across the line. We do believe that there is the potential to have one or even two significant discoveries this year. The first being our massive Prosperity Bullseye Gold-Copper-Moly porphyry drill target at Lucky Strike and our large area of volcanic breccia outcrop that has widespread mineralization of Copper-Silver exposed at surface at Copperhead…

The full CEO interview may be viewed at online.

Articles, excerpts, commentary and reviews herein are for information purposes and are not solicitations to buy or sell any of the securities mentioned.

Fredrick William
Market Equities Research Group
email us here

Goliath Resources’ Prosperity Bullseye Zone

Source: EIN Presswire

W. J. Wiess and A.S. Lynch invitation to SMi’s Superbugs & Superdrugs USA Conference

SMi's Superbugs & Superdrugs USA ConferenceSMi's Superbugs & Superdrugs USA Conference Chairs Letter

SMi’s Superbugs & Superdrugs USA ConferenceSMi’s Superbugs & Superdrugs USA Conference Chairs Letter

SMi Group reports: W. J. Weiss – University of North Texas Health Science Center and A. S. Lynch – Janssen supporting Superbugs & Superdrugs USA Conference

ISELIN, NEW JERSEY, USA, July 11, 2018 / — William and Anthony are chairing SMi's Superbugs & Superdrugs USA Conference and encourage all involved in AMR to join experts from multiple disciplines, in the field of infectious disease representing research, regulatory, funding, diagnostics and academia, at this event in New Jersey on November 12 -13, 2018.

Superbugs & Superdrugs USA Conference will become a platform where participants will get exposure to presentations and discussions focusing on supporting antimicrobial research and development, funding opportunities and resources for companies, new diagnostics for clinical applications, as well as novel therapies and approaches being undertaken for the future prevention and treatment of MDR infections.

Read on below the official letter from the chairs to participants, and reserve your ticket to attend SMi's Superbugs & Superdrugs USA Conference via

Official address
In the last decade we have witnessed a dramatic increase in both the proportion and absolute number of bacterial pathogens exhibiting multidrug resistance to current antibacterial agents. Organizations such as the US Centers for Disease Control and Prevention (CDC), the European Centre for Disease Prevention and Control (ECDC) and the World Health Organization (WHO) are considering infections caused by multi-drug resistant (MDR) bacteria as an emergent global disease and a major public health problem.

This ‘antibiotic resistance crisis’ has been compounded by a lagging in investments in antibiotic discovery and development programs in recent years, particularly as made by large pharmaceutical companies.

The emergence of MDR resistant microorganisms, either by mutation or the acquisition of mobile genetic elements carrying resistance genes, is driven through inappropriate antibiotic use but also likely takes place irrespective of exposure to antimicrobial agents. Increasing collaboration among concerned stakeholders to establish policies, initiatives, and investments in new agents to battle the antibiotic resistance crisis is promising. However, while recently approved antibiotic agents will likely help stem this crisis, novel approaches to the prevention and treatment of MDR infections are needed to ensure a viable antimicrobial armamentarium for the future.

The 3rd SMI USA Superbugs & Superdrugs meeting will bring together expertise from individuals in multiple disciplines in the field of infectious disease representing research, regulatory, funding, diagnostics and academia.

We look forward to meeting you in New Jersey in November 2018!

William J. Weiss, Director of PreClinical Services, UNT System College of Pharmacy
A. Simon Lynch, Senior Scientific Director, Janssen Research & Development

Further details at

Twitter – @SMIpharm & #smibugs
LinkedIn – SMi Pharma

+44 (0)20 7827 6000

Superbugs & Superdrugs USA Conference| November 12 – 13, 2018 | New Jersey

Lyudmyla Durneva
SMi Group
+44 (0)20 7827 6000
email us here

Source: EIN Presswire

Treating Dental Pain with Lasers to be Addressed in Webinar with Expert Technology Developer, Dr. Nelson Marquina

Dr. Nelson Marquina

A Deep dive into the how and why of laser therapy for treating common dental presentations like dentin hypersensitivity with time for your Q&A's.

RICHMOND, VIRGINIA, USA, July 10, 2018 / — Oral-facial pain can be debilitating to thousands of people. Unable to eat certain foods or liquids, brush their teeth or lord forbid, have to go to the dentist, the result is teeth that have gone uncared for and contributes to a growing number of health issues that extend beyond the mouth.

Many practitioners have recognized the use of lasers in dentistry with offering numerous highly useful and effective applications. One of the most exciting is that of laser biostimulation. By applying high intensity, non ablative laser light, cellular physiology is activated and promotes a proliferation of healthy tissue.
Over 230 positive university led worldwide studies have shown an 80%-95% success rate on more than 24 different dental applications. Using high intensity laser biostimulation, patients enjoy results from the pain and swelling associated with tooth sensitivities, periodontal disease, pulpitis, neuralgia, headaches, TMD and more.

So if your patients complain of "dental pain" and dentine hypersensitivity this webinar will provide you with another way of using laser therapy that complements conventional treatment protocols we invite your to join our "Dentin Hypersensitivity Made Easy" webinar on July 13th, 2018 from Noon-12:45 EST

Pre-registeration is required.

You can do this by calling 1.877.423.6169
or email

Once you are registered for the webinar you will receive a link and password to join in live

Have questions you would like answered on the webinar
Email them prior to the webinar at×110.jpeg

Dr. Nelson Marquina, MSc, PhD, DC

Dr. Marquina's early interest in light yielded to space research, robotics engineering, AI, human physiology and biochemistry. His scientific contributions to leading edge technology applications in various industries reflect his commitment to the practical and valuable benefits of continued learning. He is known for his enjoyable and effective teaching style and down-to-earth, hands-on approach to laser therapy. Dr. Nelson Marquina is a developer of photonic and bioelectromagnetic systems and treatment protocols and is an author of scientific chapters and articles in healthcare texts and journals.

Elizabeth A. Southard
Laser Biotech International
email us here

Source: EIN Presswire

Local Physician Looks to Disrupt Healthcare with Management Services Organization for Independent Physicians

The CEO of Vein911® announced the launch of Health Performance Specialists (HPS), a Management Services Organization for independent physicians.

Changing regulations, policies, and technology are forcing doctors to spend a burdensome amount of time on administrative tasks and not enough on their patients.”

— Chris Pittman, M.D., CEO of Health Performance Specialists

TAMPA, FL, USA, July 10, 2018 / — The CEO of Vein911® Vein Treatment Centers, 21-year cancer survivor, and healthcare industry veteran, Chris Pittman, M.D., announced today the official launch of Health Performance Specialists (HPS), a national Management Services Organization for independent physicians. HPS helps independent physicians compete, succeed, and thrive in today's medical practice environment. The organization is designed to disrupt current healthcare delivery by uniting top quality independent physicians, so they can profit from economies of scale without sacrificing the benefits of being small. The benefits include group purchasing agreements, sharing operational and information technology solutions, leveraging common back office staff, and analyzing healthcare data for better patient outcomes – benefits usually enjoyed by physicians employed by large groups or hospitals.

Yet, research shows that small, physician-owned practices provide better responsiveness to patient needs, have lower average cost per patient, and fewer hospital admissions than large, independent- and hospital-owned practices. Independent physicians are over-burdened by the rising cost of government reporting, information technology, and changing reimbursement models. Many physicians have been forced to sell their practice and become employees of larger physician groups or hospitals. HPS was created to level the playing field across the ever-consolidating medical-industrial complex. The HPS team assists or assumes any or all practice functions so physicians can remain engaged with their patients and provide the best care possible.

“The healthcare environment is changing like a tsunami, volcano, or hurricane changes the landscape, making it difficult for doctors to continue operating independently,” said Chris Pittman, M.D., CEO of Health Performance Specialists. “Changing regulations, policies, and technology are forcing doctors to spend a burdensome amount of time on administrative tasks and not enough on their patients. HPS is designed to help physicians who understand the value of small practices and share our mission of Engaged Physicians. Delighted Patients.”

About Health Performance Specialists
Health Performance Specialists, LLC, is a physician-led Management Services Organization network of independent physicians that helps physicians to compete, succeed, and thrive. A 21-year cancer survivor with over 25 years in medical practice and practice management our Managing Director, Christopher Pittman, M.D., understands what medical practices need to be successful in a constantly changing healthcare marketplace. He is a nationally recognized expert in health care policy, medical economics, and health information technology including EMR, medical informatics, and telemedicine. HPS executive team members are nationally recognized experts in digital media, design thinking, operations, and financial intelligence. Our team provides industry leading services to aligned network physicians who positively benefit together, along with our patients.

About Vein911® Vein Treatment Centers
Vein911® is a leading provider of both medical and cosmetic vein care including varicose veins, ankle swelling, restless legs, night cramps, venous leg ulcers, and cosmetically disturbing veins of the hands, face and legs. Our world-class vein treatment centers offer state of the art technology within elegant and comfortable surroundings and a family atmosphere. Our non-surgical medical procedures include VenaCure EVLT Endovenous Laser Treatment, Venefit procedure using ClosureFast Endovenous Radiofrequency Ablation (RFA) and Ultrasound-Guided Foam Sclerotherapy which is the future of vein care available today at Vein911®. Our cosmetic procedures include Visual Sclerotherapy, the gold standard treatment for spider veins, and VeinGogh, an immediately effective treatment for facial veins. Vein911® is the varicose vein and spider vein treatment center of choice for physicians and their patients who are experiencing vein disease. Our vein treatment centers are conveniently located throughout the Tampa Bay area and are led by board-certified vein care specialist physicians.

Chris Pittman
Health Performance Specialists
email us here

Source: EIN Presswire